When Chemical Biology meets Drug Design
Nice, France July 3-5, 2013
University of Nice Sophia Antipolis, Nice, France
University of Nice Sophia Antipolis, Nice, France
University of Nice Sophia Antipolis, Nice, France
University of Nice Sophia Antipolis, Nice, France
University of Nice Sophia Antipolis, Nice, France
University Lille 2, Lille, France
University of Nice Sophia Antipolis, Nice, France
University of Nice Sophia Antipolis, Nice, France
SCT & Independent Scientific Expert & Adviser, Longvilliers, France
SCT & University of Reims-Champagne-Ardenne, Reims, France
Institut Curie, Paris, France
SCT & NovAliX, Nijmegen, The Netherlands
University of Nice Sophia Antipolis, Nice, France
Institut Pasteur - CNRS, Paris, France
Novartis Institute for BioMedical Research, Basel, Switzerland
INSERM, Brest, France
Merck Serono, Darmstadt, Germany
Università di Pisa, Pisa, Italy
GSK, Courtaboeuf, France
Differding Consulting, Louvain-la-Neuve, Belgium
CEA, Gif-sur-Yvette, France
University of Basel, Zürich, Switzerland
Sanofi, Vitry sur Seine, France
CNRS-Université Montpellier-II, Montpellier, France
University of Bordeaux, CBMN, Bordeaux, France
Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
University of York & Vernalis, Cambridge, United Kingdom
Oxford University, Oxford, United Kingdom
ManRos Therapeutics, Roscoff, France
Université Paris Descartes, Paris, France
F. Hoffmann-La Roche, Basel, Switzerland
Forest Research Institute, Hauppauge, United States
Astex Pharmaceuticals, Cambridge, United Kingdom
Bayer Pharma, Wuppertal, Germany
Addex Therapeutics, Plan-les-Ouates, Switzerland
Grünenthal, Verona, Italy
University of Firenze, Sesto Fiorentino, Italy
Pfizer, Sandwich, Kent, United Kingdom
AstraZeneca, Newcastle upon Tyne, United Kingdom
University of Geneva, Geneva, Switzerland